PT1355639E - Derivados de carboestirilo substituidos como agonistas do subtipo de receptores 5-ht1a - Google Patents

Derivados de carboestirilo substituidos como agonistas do subtipo de receptores 5-ht1a

Info

Publication number
PT1355639E
PT1355639E PT02716434T PT02716434T PT1355639E PT 1355639 E PT1355639 E PT 1355639E PT 02716434 T PT02716434 T PT 02716434T PT 02716434 T PT02716434 T PT 02716434T PT 1355639 E PT1355639 E PT 1355639E
Authority
PT
Portugal
Prior art keywords
carboxyryl
derivatives
substituted
receptor subtype
ht1a receptor
Prior art date
Application number
PT02716434T
Other languages
English (en)
Inventor
Jordan Shaun
Kikuchi Tetsuro
Tottori Katsura
Hirose Tsuyoshi
Uwahodo Yasufumi
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25087808&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1355639(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of PT1355639E publication Critical patent/PT1355639E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
PT02716434T 2001-01-29 2002-01-29 Derivados de carboestirilo substituidos como agonistas do subtipo de receptores 5-ht1a PT1355639E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77021001A 2001-01-29 2001-01-29

Publications (1)

Publication Number Publication Date
PT1355639E true PT1355639E (pt) 2006-06-30

Family

ID=25087808

Family Applications (3)

Application Number Title Priority Date Filing Date
PT05023971T PT1621198E (pt) 2001-01-29 2002-01-29 Derivados de carboestirilo substituídos como agonistas do subtipo 1a de receptores 5-ht
PT02716434T PT1355639E (pt) 2001-01-29 2002-01-29 Derivados de carboestirilo substituidos como agonistas do subtipo de receptores 5-ht1a
PT06015782T PT1712225E (pt) 2001-01-29 2002-01-29 Derivados substituídos de carbostirilo como agonistas do subtipo de receptor 5-ht1a para o tratamento do distúrbio bipolar

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT05023971T PT1621198E (pt) 2001-01-29 2002-01-29 Derivados de carboestirilo substituídos como agonistas do subtipo 1a de receptores 5-ht

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT06015782T PT1712225E (pt) 2001-01-29 2002-01-29 Derivados substituídos de carbostirilo como agonistas do subtipo de receptor 5-ht1a para o tratamento do distúrbio bipolar

Country Status (20)

Country Link
EP (3) EP1355639B1 (pt)
JP (4) JP4178032B2 (pt)
KR (5) KR100825705B1 (pt)
CN (3) CN1879624A (pt)
AR (4) AR032641A1 (pt)
AT (3) ATE362763T1 (pt)
AU (4) AU2002226752C1 (pt)
BR (1) BR0206237A (pt)
CA (2) CA2429496C (pt)
CY (3) CY1105631T1 (pt)
DE (3) DE60239711D1 (pt)
DK (3) DK1712225T3 (pt)
ES (3) ES2286755T3 (pt)
HK (2) HK1061805A1 (pt)
MX (2) MXPA03006603A (pt)
MY (1) MY129355A (pt)
PH (1) PH12014500937A1 (pt)
PT (3) PT1621198E (pt)
TW (2) TWI331919B (pt)
WO (1) WO2002060423A2 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053092B2 (en) 2001-01-29 2006-05-30 Otsuka Pharmaceutical Co., Ltd. 5-HT1a receptor subtype agonist
AR032641A1 (es) * 2001-01-29 2003-11-19 Otsuka Pharma Co Ltd Agonista de subtipo de receptor 5-ht 1a.
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
US8703772B2 (en) 2001-09-25 2014-04-22 Otsuka Pharmaceutical Co., Ltd. Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
DE10148233A1 (de) * 2001-09-28 2003-04-10 Boehringer Ingelheim Pharma Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme
CA2529857A1 (en) * 2002-07-30 2004-02-05 Peter Migaly Combination therapy for depression, prevention of suicide, and varous medical and psychiatric conditions
AR042806A1 (es) 2002-12-27 2005-07-06 Otsuka Pharma Co Ltd Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
MXPA05006857A (es) 2002-12-27 2005-08-18 Otsuka Pharma Co Ltd Derivados de carbostirilo e inhibidores de la recaptacion de serotonina para el tratamiento de desordenes en el humor.
CN102172402A (zh) 2003-05-23 2011-09-07 大塚制药株式会社 用于治疗情感障碍的喹诺酮衍生物和情绪稳定剂
US7160888B2 (en) * 2003-08-22 2007-01-09 Warner Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
FR2865650B1 (fr) * 2004-01-30 2008-06-13 Biocortech Utilisation du 14,15 dihydro 20,21-dinoreburnamenin14-ol pour traiter et/ou prevenir les depressions majeures et les desordres du cycle veille-sommeil
WO2006090273A2 (en) * 2005-02-22 2006-08-31 Warner-Lambert Company Llc [1,8]naphthyridin-2-ones and related compounds with keto or hydroxyl linkers for the treatment of schizophrenia
PL1912650T3 (pl) * 2005-08-03 2018-01-31 Sprout Pharmaceuticals Inc Zastosowanie flibanseryny w leczeniu otyłości
TW200848041A (en) * 2007-03-30 2008-12-16 Otsuka Pharma Co Ltd A medicament for treating schizophrenia comprising cilostazol
GB2456183A (en) 2008-01-04 2009-07-08 Gw Pharma Ltd Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament
JP2009286740A (ja) * 2008-05-30 2009-12-10 Otsuka Pharmaceut Co Ltd アリピプラゾールを含有する逆耐性抑制剤
EP2338873A1 (en) 2009-12-22 2011-06-29 Gmeiner, Peter New aminotetraline derivatives
AR090245A1 (es) 2012-03-06 2014-10-29 Otsuka Pharma Co Ltd Preparacion solida oral de liberacion sostenida, metodo de preparacion
JOP20200109A1 (ar) 2012-04-23 2017-06-16 Otsuka Pharma Co Ltd مستحضر قابل للحقن

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54130587A (en) * 1978-03-30 1979-10-09 Otsuka Pharmaceut Co Ltd Carbostyryl derivative
JPS5646812A (en) * 1979-09-27 1981-04-28 Otsuka Pharmaceut Co Ltd Central nervous system depressant
DE3721799C2 (de) 1986-07-01 1993-12-23 Mitsubishi Electric Corp Integrierte Redox-Bauelementschaltung und Verfahren zum Herstellen
JP2608788B2 (ja) * 1988-10-31 1997-05-14 大塚製薬 株式会社 精神分裂病治療剤
US5006528A (en) * 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
WO1992020655A1 (en) * 1991-05-20 1992-11-26 The Upjohn Company Carboxamido-(1,2n)-carbocyclic-2-aminotetralin derivatives
US5532240A (en) * 1991-12-26 1996-07-02 Yoshitomi Pharmaceutical Industries, Ltd. Condensed thiophene compound and pharmaceutical use thereof
AU5446894A (en) * 1992-10-23 1994-05-24 New York University Functional interactions between glial s-100b and central nervous system serotonergic neurons
DK148292D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Forbindelser
JP2959615B2 (ja) * 1993-06-24 1999-10-06 吉富製薬株式会社 縮合型チオフェン化合物およびその医薬用途
JPH09291034A (ja) * 1996-02-27 1997-11-11 Yoshitomi Pharmaceut Ind Ltd 縮合ピリジン化合物およびその医薬としての用途
US5688950A (en) * 1996-04-23 1997-11-18 Neurogen Corporation Tricyclic aminoalkylcarboxamides; novel dopamine D3 receptor subtype specific ligands
WO1997042190A1 (en) * 1996-05-07 1997-11-13 Pfizer Inc. Mesylate trihydrate salt of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2(1h)-indol-2-one (=ziprasidone), its preparation and its use as dopamine d2 antagonist
JP4012994B2 (ja) * 1996-05-08 2007-11-28 大塚製薬株式会社 抗不安薬
DE69719765T2 (de) * 1996-08-27 2003-10-16 Wyeth Corp 4-aminoethoxy-indolderivate als dopamin d2 agonisten und als 5ht1a liganden
CA2317515A1 (en) * 1998-02-03 1999-08-05 Frances Christy Nelson Oxazole derivatives as serotonin-1a receptor agonists
ZA992670B (en) * 1998-04-13 2000-10-12 American Home Prod 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists.
JPH11335286A (ja) * 1998-05-25 1999-12-07 Mitsui Chem Inc ドーパミン拮抗薬の効果増強剤
AR032641A1 (es) * 2001-01-29 2003-11-19 Otsuka Pharma Co Ltd Agonista de subtipo de receptor 5-ht 1a.
DK1397145T3 (da) * 2001-06-19 2007-01-02 Norbert Mueller Anvendelse af COX-2-inhibitorer til behandling af schizophrenia eller tics-lidelser
AR033485A1 (es) * 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma

Also Published As

Publication number Publication date
DE60220325D1 (de) 2007-07-05
DK1621198T3 (da) 2007-09-24
KR100825705B1 (ko) 2008-04-29
AU2002226752B2 (en) 2005-03-17
AU2005201772A1 (en) 2005-05-19
ES2363366T3 (es) 2011-08-02
JP4178032B2 (ja) 2008-11-12
CA2429496A1 (en) 2002-08-08
WO2002060423A2 (en) 2002-08-08
CA2700314A1 (en) 2002-08-08
JP4896831B2 (ja) 2012-03-14
DK1355639T3 (da) 2006-08-14
KR20030065570A (ko) 2003-08-06
EP1621198A3 (en) 2006-04-12
AR099754A2 (es) 2016-08-17
DE60239711D1 (de) 2011-05-19
KR100653591B1 (ko) 2006-12-05
KR100763288B1 (ko) 2007-10-04
AR032641A1 (es) 2003-11-19
ATE362763T1 (de) 2007-06-15
JP2007297405A (ja) 2007-11-15
MX344556B (es) 2016-12-20
EP1355639B1 (en) 2006-04-12
ES2261652T3 (es) 2006-11-16
AU2005201772C1 (en) 2010-06-03
TWI302832B (en) 2008-11-11
JP2011225587A (ja) 2011-11-10
AU2007201701A1 (en) 2007-05-10
KR100713607B1 (ko) 2007-05-02
CN1813745A (zh) 2006-08-09
CN100450485C (zh) 2009-01-14
DE60210581D1 (en) 2006-05-24
HK1091403A1 (en) 2007-01-19
KR20070065425A (ko) 2007-06-22
ATE322894T1 (de) 2006-04-15
AU2007201701B2 (en) 2010-06-17
JP2011184460A (ja) 2011-09-22
EP1621198A2 (en) 2006-02-01
PT1621198E (pt) 2007-06-08
AU2002226752C1 (en) 2010-02-18
ATE504293T1 (de) 2011-04-15
MY129355A (en) 2007-03-30
CN1879624A (zh) 2006-12-20
EP1355639A2 (en) 2003-10-29
EP1712225B1 (en) 2011-04-06
PT1712225E (pt) 2011-04-18
PH12014500937A1 (en) 2015-09-21
EP1712225A1 (en) 2006-10-18
MXPA03006603A (es) 2004-02-12
KR20060085260A (ko) 2006-07-26
KR100601073B1 (ko) 2006-07-19
CN1239154C (zh) 2006-02-01
WO2002060423A3 (en) 2003-04-10
TWI331919B (en) 2010-10-21
CN1484524A (zh) 2004-03-24
DK1712225T3 (da) 2011-06-20
HK1061805A1 (en) 2004-10-08
AU2005201772B2 (en) 2007-05-17
CA2429496C (en) 2010-10-19
TW200522960A (en) 2005-07-16
DE60220325T2 (de) 2008-01-17
AR080849A2 (es) 2012-05-09
AU2009233591A1 (en) 2009-11-19
JP2004517937A (ja) 2004-06-17
CA2700314C (en) 2012-04-24
EP1621198B1 (en) 2007-05-23
CY1108031T1 (el) 2013-09-04
KR20060028485A (ko) 2006-03-29
KR20050107822A (ko) 2005-11-15
ES2286755T3 (es) 2007-12-01
JP5683010B2 (ja) 2015-03-11
CY1105631T1 (el) 2010-12-22
AR079761A2 (es) 2012-02-15
AU2009233591B2 (en) 2011-10-20
DE60210581T2 (de) 2007-04-05
BR0206237A (pt) 2003-12-23
CY1111392T1 (el) 2015-08-05

Similar Documents

Publication Publication Date Title
PT1355639E (pt) Derivados de carboestirilo substituidos como agonistas do subtipo de receptores 5-ht1a
PT1444215E (pt) Derivados de 1,2,4-triadiazolio como moduladores do receptor de melanocortina
ATE370120T1 (de) Substituierte 2-pyridin-cyclohexan-1,4- diaminderivate
DK1446379T3 (da) Arylanilin-beta2-adrenergiske receptoragonister
PT1379511E (pt) Derivados de di-hidro-benzo[b] [1,4] diazepin-2-ona como antagonistas ii de r2glum
PT1309559E (pt) Derivados de 4-fenil-piridina como antagonistas do receptor de neuroquinina-1
PT1349839E (pt) Derivados de feniletenilo ou feniletinilo como antagonistas do receptor de glutamato
DE60225563D1 (de) 4-amino-6-phenyl-pyrroloä2,3-düpyrimidin derivate
DOP2005000024A (es) 2,3,4,5-tetrahidro-1h-benzo[d]azepinas 6-sustituidas como agonistas del receptor 5-ht2c
PT1049689E (pt) Compostos de 4-(2-ceto-1-benzimidazolinil)piperidina como agonistas do receptor orl1
SMP200600024B (it) 2,6-Biseteroaril-4-amminopirimidine come antagonisti del recettore dell'adenosina
PT1379522E (pt) Derivados de di-hidro-benzo[b] [1,4] diazepina-2-ona como antagonistas i do r2glum
PT1198453E (pt) Derivados de n-(indolcarbonil)-piperazina como ligandos do receptor 5-ht2a
PT1216239E (pt) Derivados de piperazina como antagonistas de 5-ht1b
DE60317365D1 (de) Substituierte 4-alkoxyoxazol derivate als ppar agonisten
EE200400088A (et) CCR1 retseptori suhtes antagonistlikku aktiivsustomavad piperasiiniderivaadid
PT1226131E (pt) Derivados de isoxazolecarboxamida como antagonistas do receptor adrenergico alfa1
DE602004021250D1 (de) 2-alkinyl- und 2-alkenyl-pyrazolo-ä4,3-eü -1,2,4-triazolo-ä1,5-cü -pyrimidinadenosin a2a rezeptorantagonisten
ATE306265T1 (de) Benzothiazolderivate als adenosin-rezeptor- liganden
DE60316411D1 (de) Thiazolderivate als npy-rezeptorantagonisten
ATE492535T1 (de) 4-piperidinylalkylamin-derivate, antagonisten von muscarinrezeptoren
ATE395333T1 (de) 4-phenylpiperazinyl, -piperidinyl und - tetrahydropyridyl-derivate als dopamin d4- antagonisten
PT1176144E (pt) Novos derivados de n-triazolilmetil piperazina como antagonistas do receptor da neuroquinina
ATE338043T1 (de) 5-methoxy-8-aryl- 1,2,4ötriazolo 1,5-aöpyridine derivative als adenosin-rezeptor antagonisten
NO20054141D0 (no) Substituerte 2-(diaza-bicykloalkyl)pyrimidonderivater